MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands
Eun Joo Chung, Mary Ellen Urick, Naamit Kurshan, William Shield, Hiroaki Asano, Paul D. Smith, Bradley S. Scroggins, Jeffrey Burkeen, Deborah E. Citrin
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands'. Together they form a unique fingerprint.